The Transulnar Approach in the Patients With Ipsilateral Radial Artery Occlusion

The Transulnar Approach in the Patients With Ipsilateral Radial Artery Occlusion Publisher

Roghanidehkordi F¹ ; Hosseinzadeh H¹ ; Khosravi A¹ ; Vakhshoori M² ; Kermani M¹ ; Sadeghi M³ ; Danesh M⁴ ; Sadeghi N⁵ ; Sahfie D²

Show Affiliations

1. Interventional Cardiology Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
2. Heart Failure Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
3. Cardiac Rehabilitation Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
4. Hypertension Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
5. Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran

Source: ARYA Atherosclerosis Published:2020

Abstract

BACKGROUND: Transulnar approach (TUA) has been classified as an appropriate surrogate for the transradial approach (TRA), but the safety of TUA in the presence of ipsilateral radial artery occlusion (RAO) is not well studied. In this article, we aimed to assess the feasibility and occurrence of complications of this approach in Iranian individuals with ipsilateral RAO. METHODS: In this prospective double-center study, a total number of 70 participants from July 2017 to November 2018 with coexisting ipsilateral RAO due to prior RA angiography, severe arterial spasm, prominent vascular anomalies, or arterial harvesting for hemodialysis or graft procedures were enrolled and underwent TUA. Incidence of probable complications including pain, hematoma, arteriovenous fistula (AVF), pseudoaneurysm formation, any adverse events requiring immediate vascular surgery, life-threatening hand ischemia, infection, ulnar nerve palsy, major adverse cardiac events (MACE) including death, myocardial infarction (MI), or stroke plus ulnar artery (UA) obstruction and narrowing was evaluated both before discharge time and one month afterward. RESULTS: The mean age of the study population was 68.2 ± 12.8 years [men number: 41 (58.5%)]. Our success rate was 98.6% and 37.1% of subjects underwent further coronary intervention. No aforementioned adverse outcomes were reported in any individual except for pain (11.4%) and minor hematoma (grade I) (5.7%) as well as MACE (1.4%). Follow-up assessment revealed asymptomatic UA occlusion (UAO) and severe narrowing in 2.8% and 1.4% of participants, respectively. CONCLUSION: Our outcomes suggested that due to high safety and low complication rates, TUA could be tried safely in patients with concurrent ipsilateral RAO. Other appropriate cohort studies are required for assessing the incidence of TUA complications. © 2020, Isfahan University of Medical Sciences(IUMS). All rights reserved.

Related Docs

View other Related Docs

1. Transulnar Versus Transradial Approach for Coronary Angiography and Angioplasty: Considering Their Complications, ARYA Atherosclerosis (2018)

2. Distal Accesses in the Hand (Two Novel Techniques) for Percutaneous Coronary Angiography and Intervention, ARYA Atherosclerosis (2018)

3. What Is the Preferred Hemostasis Method for Coronary Angiography Through the Palmar Artery Access?, Cardiovascular Intervention and Therapeutics (2021)

4. Percutaneous Trans-Ulnar Artery Approach for Coronary Angiography and Angioplasty; a Case Series Study, ARYA Atherosclerosis (2015)

5. Trans-Snuff Box Approach As a New Access Site for Coronary Angiography and Angioplasty Versus Trans-Radial Approach in Terms of Feasibility, Safety, and Complications, ARYA Atherosclerosis (2020)

6. Comparison of Pain Severity, Satisfaction, and Complications of Proximal and Distal Forearm Anesthesia in Patients Undergoing Trans-Palmar Coronary Angiography, Anatolian Journal of Cardiology (2022)

7. Crossover From Transradial to Ipsilateral Transulnar Access After Sheath Insertion Into the Radial Artery, Kardiologia Polska (2020)

8. Apixaban, a Novel Oral Anticoagulant, Use to Resolute Arterial Patency in Radial Artery Occlusion Due to Cardiac Catheterization; a Pilot Randomized Clinical Trial, ARYA Atherosclerosis (2023)

Experts (# of related papers)

View all Related Experts

Farshad Roghani (7)

Masoumeh Sadeghi (3)

Style	Citing Format
MLA	Roghanidehkordi F, et al.. "The Transulnar Approach in the Patients With Ipsilateral Radial Artery Occlusion." ARYA Atherosclerosis, vol. 16, no. 1, 2020, pp. 33-38.
APA	Roghanidehkordi F, Hosseinzadeh H, Khosravi A, Vakhshoori M, Kermani M, Sadeghi M, Danesh M, Sadeghi N, Sahfie D (2020). The Transulnar Approach in the Patients With Ipsilateral Radial Artery Occlusion. ARYA Atherosclerosis, 16(1), 33-38.
Chicago	Roghanidehkordi F, Hosseinzadeh H, Khosravi A, Vakhshoori M, Kermani M, Sadeghi M, Danesh M, Sadeghi N, Sahfie D. "The Transulnar Approach in the Patients With Ipsilateral Radial Artery Occlusion." ARYA Atherosclerosis 16, no. 1 (2020): 33-38.
Harvard	Roghanidehkordi F et al. (2020) 'The Transulnar Approach in the Patients With Ipsilateral Radial Artery Occlusion', ARYA Atherosclerosis, 16(1), pp. 33-38.
Vancouver	Roghanidehkordi F, Hosseinzadeh H, Khosravi A, Vakhshoori M, Kermani M, Sadeghi M, et al.. The Transulnar Approach in the Patients With Ipsilateral Radial Artery Occlusion. ARYA Atherosclerosis. 2020;16(1):33-38.
BibTex	@article{ author = {Roghanidehkordi F and Hosseinzadeh H and Khosravi A and Vakhshoori M and Kermani M and Sadeghi M and Danesh M and Sadeghi N and Sahfie D}, title = {The Transulnar Approach in the Patients With Ipsilateral Radial Artery Occlusion}, journal = {ARYA Atherosclerosis}, volume = {16}, number = {1}, pages = {33-38}, year = {2020} }
RIS	TY - JOUR AU - Roghanidehkordi F AU - Hosseinzadeh H AU - Khosravi A AU - Vakhshoori M AU - Kermani M AU - Sadeghi M AU - Danesh M AU - Sadeghi N AU - Sahfie D TI - The Transulnar Approach in the Patients With Ipsilateral Radial Artery Occlusion JO - ARYA Atherosclerosis VL - 16 IS - 1 SP - 33 EP - 38 PY - 2020 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract